Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01550939
Other study ID # HS1 Time Study 2
Secondary ID
Status Completed
Phase Phase 4
First received March 5, 2012
Last updated July 31, 2012
Start date January 2012
Est. completion date March 2012

Study information

Verified date July 2012
Source Haag Streit USA
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objectives of this study are to determine the time needed to complete a full set of measurements (Total Ophthalmic Exam, Subject Data Entry and Acquisition of the Measurement) by each test device, the Lenstar 900 Version i4 and IOL Master 500.


Description:

This is an open-label study randomized by sequence. Each eligible subject who signs a consent form and fulfills all Inclusion/Exclusion criteria will undergo ophthalmic measurements by the two test products:

A. Haag-Streit Lenstar Version i4

B. Zeiss IOL Master 500

The order of measurements for the IOL Master 500 and the Haag-Streit Lenstar Version i4 will he randomized. The two possible sequences will be balanced (approximately 22 eyes each: AB,BA). One eye of each subject will be measured. Time needed to complete testing will be measured utilizing a stop-watch. Total time needed to complete all measurements of the study eye using each of the test products to capture a complete ophthalmic exam with the devices standard operating settings set to automatic measurement and analysis will be calculated by the following start and stop points:

First Timed Measurement: Measurement Acquisition Start: When the technician starts to acquire tbe first measurement Stop: When the technician has completed all measurements

Second Timed Measurement: Subject Data Entry Start: When the technician starts to enter the subject data. Stop: When the technician has completed subject data entry.

Third Timed Measurement: Complete Ophthalmic Exam with each test product Start: When tbe subject is seated at the instrument, just prior to the technician entering any subject data into the test product.

Stop: Upon completion of all measurements using one of the test products, just prior to printing results.

Three trained technicians will operate tbe same study devices (Haag-Streit Lenstar Version i4 and IOL Master 500). Approximately equal number of subjects will be assigned to each technician.


Recruitment information / eligibility

Status Completed
Enrollment 61
Est. completion date March 2012
Est. primary completion date March 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

Subjects wbo meet all of the following criteria are eligible to participate in tbe study:

1. Male or female l8 years of age or older on the date of Informed Consent.

2. At least one eye of each subject must be a phakic eye.

3. Subject must be able to fixate on a target.

4. Able to understand and willing to sign tbe informed consent.

Exclusion Criteria:

Subjects will be excluded from the study if the following applies:

1. History of corneal surgery.

2. Use of contact lenses during tbe ophthalmic exam or up to two hours prior to the exam.

3. Any ophthalmic condition preventing use of either of the instruments used in the study.

4. Any ophthalmic condition which might impair tbe validity of results from any of the instruments used in the study.

5. Any medical condition, which, in tbe Investigator's judgment, interferes with the subjects ability to comply with tbe protocol, compromises subject safety, or interferes with tbe interpretation of the study results.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Ophthalmic Biometer
One complete biometry examination

Locations

Country Name City State
United States Cincinnati Eye Institute Cincinnati Ohio

Sponsors (1)

Lead Sponsor Collaborator
Haag Streit USA

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to complete a full examination Time to complete a full ophthalmic exam(as measured from the time of subject placement just prior to the technician completing data entry at the test product, to the beginning of data printing) for each, the IOL Master 500 and the Haag-Streit Lenstar Version i4. At Study Visit (study consists of 1 visit only)
Secondary Data Entry Time Measurement Additional Time Measurements - Data Entry from the IOL Master 500 and the Haag-Streit Lenstar Version i4. At Study Visit (study consists of 1 visit only)
Secondary Measurement Acquisition Time Measurement Additional Timed Measurements - Measurement Acquisition from the IOL Master 500 and the Haag-Streit Lenstar Version i4. At Study Visit (study consists of 1 visit only)
Secondary Adverse Events Any adverse events associated with the test products Duration of study from signing informed consent to Study Visit (study consists of 1 visit only)
See also
  Status Clinical Trial Phase
Recruiting NCT04224129 - Characterization and Causative Factors of Negative Dysphotopsia
Completed NCT02138123 - Intraocular Lens-shell Technique in Phacoemulsification N/A